Received Apr 30, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Inappropriate reconstitution; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong technique in product usage process in a patient who received MMR (Priorix) for prophylaxis. On an unknown date, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced wrong technique in product usage process (Verbatim: Inappropriate reconstitution). The outcome of the wrong technique in product usage process was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date 22-APR-2026 The Priorix was reconstituted with a diluent other than the accompanying syringe, however, the diluent used was from another syringe intended for Priorix. The pharmacist did not provide any further details about the incident. The lot number, expiration date, and patient details were not shared. The reporter did not consent to follow-up. The batch number was not provided upon follow- up with the reporter.